Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Peptides
|
November 1, 1988
Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth
G Bepler, U Zeymer, S Mahmoud, et al.
Cancer Detection and Prevention
|
September 4, 2001
Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities
T Aloia, G Bepler, D Harpole, et al.
BMC Cancer
|
July 27, 2001
MCM2--a promising marker for premalignant lesions of the lung: a cohort study
D F Tan, J A Huberman, A Hyland, et al.
Journal of Cell Science
|
September 1, 1988
Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines
J L Broers, M K Rot, T Oostendorp, et al.
Cancer Detection and Prevention
|
February 18, 1998
Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer
G Bepler, K M Fong, B E Johnson, et al.
Cancer Research
|
June 1, 1985
Establishment and identification of small cell lung cancer cell lines having classic and variant features
D N Carney, A F Gazdar, G Bepler, et al.
Cancer Investigation
|
December 9, 2009
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy
G Metro, Z Zheng, A Fabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2001
MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer
N Ramnath, F J Hernandez, D F Tan, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 1, 1992
Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines
M A Verbeeck, J P Elands, L F de Leij, et al.
Oncogene
|
June 23, 2009
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
H Akita, Z Zheng, Y Takeda, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Peptides
|
November 1, 1988
Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth
G Bepler, U Zeymer, S Mahmoud, et al.
Cancer Detection and Prevention
|
September 4, 2001
Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities
T Aloia, G Bepler, D Harpole, et al.
BMC Cancer
|
July 27, 2001
MCM2--a promising marker for premalignant lesions of the lung: a cohort study
D F Tan, J A Huberman, A Hyland, et al.
Journal of Cell Science
|
September 1, 1988
Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines
J L Broers, M K Rot, T Oostendorp, et al.
Cancer Detection and Prevention
|
February 18, 1998
Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer
G Bepler, K M Fong, B E Johnson, et al.
Cancer Research
|
June 1, 1985
Establishment and identification of small cell lung cancer cell lines having classic and variant features
D N Carney, A F Gazdar, G Bepler, et al.
Cancer Investigation
|
December 9, 2009
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy
G Metro, Z Zheng, A Fabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2001
MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer
N Ramnath, F J Hernandez, D F Tan, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 1, 1992
Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines
M A Verbeeck, J P Elands, L F de Leij, et al.
Oncogene
|
June 23, 2009
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
H Akita, Z Zheng, Y Takeda, et al.
Page
of 7